Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by PLITheOneon Aug 09, 2021 9:27am
45 Views
Post# 33671089

RE:Pathetic,73 millions only will be kept by Liminal, not 105M$

RE:Pathetic,73 millions only will be kept by Liminal, not 105M$Not only that eric, they paid Kedrion to take away ALL future potential revenue from EVERY protien derived from PPPS! It's discusting what Thomvest has done to this company and investors!

Bring on the lawsuit to expose these Aholes!!!!

eric40 wrote: What company would give away a product and technology developped for almost a billion dollar and now approuved by FDA and give 32 millions US with it.?  If they did not want to bother with marketing plasminogene, they could have simply put it on the shelves and keep 105 millions $ of the voucher instead of 73.5 millions$ that they will receive after the PATHETIC agreement with Kedrion (even if there was no marketing needed as they had just to fill the bottle and sell it to the already known patient and make millions of $...) 

They sold the approuved Plasminogene with the FDA approuved facility that produce it for 5 millions plus they give Kedrion 30% of the voucher, so they give them 31.5 millions of $. 

SO 31.5 MILLIONS MINUS 5 MILLIONS EQUAL 26.5 MILLIONS.

This means that liminal gave 26.5 millions of  $ PLUS the FDA approuved facility and drug to get rid of their billion dollar investment (shareholders money).

PATHETIC




<< Previous
Bullboard Posts
Next >>